Photocure $PHO.OL boost on chinese partnership deal
Photocure 
PHO today released news of a outlicensing of the Cevira franchise for commercialization, giving the stock a boost, possibly regaining foothold above the SMA50 and SMA200.
Press release
https://photocure.com/news/photocure-and-asieris-enter-into-a-global-licensing-deal-for-cevira-with-up-to-usd-250-million-in-milestones-and-double-digit-royalties/
PHO today released news of a outlicensing of the Cevira franchise for commercialization, giving the stock a boost, possibly regaining foothold above the SMA50 and SMA200.Press release
https://photocure.com/news/photocure-and-asieris-enter-into-a-global-licensing-deal-for-cevira-with-up-to-usd-250-million-in-milestones-and-double-digit-royalties/
Publikasi terkait
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.